Veno-Occlusive Disease
What is Veno-Occlusive Disease?
Veno-occlusive disease is a serious liver condition that blocks small blood vessels inside the liver. It happens when the inner lining of tiny liver blood vessels becomes damaged and swollen. This swelling blocks blood flow and causes fluid to build up in the liver.
The condition is also called sinusoidal obstruction syndrome. It most often occurs after stem cell transplants or certain types of chemotherapy. When blood cannot flow properly through the liver, the organ becomes damaged and swollen. This can affect how well your liver removes toxins and produces important proteins.
Early detection through blood testing helps doctors monitor liver function and catch problems before they become severe. Most cases develop within 3 weeks after a stem cell transplant or chemotherapy treatment. The severity ranges from mild cases that resolve on their own to severe cases that require immediate medical care.
Symptoms
- Sudden weight gain from fluid retention
- Swollen or enlarged liver that feels tender
- Pain in the upper right side of the abdomen
- Yellowing of the skin or eyes, called jaundice
- Fluid buildup in the abdomen, making it look swollen
- Dark colored urine
- Confusion or changes in mental state
- Nausea and vomiting
Some people with mild veno-occlusive disease may have few noticeable symptoms at first. Blood tests often detect liver problems before physical symptoms become obvious. This is why regular monitoring is important after stem cell transplants or chemotherapy.
Concerned about Veno-Occlusive Disease? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Veno-occlusive disease happens when the inner lining of small liver blood vessels gets damaged. The most common cause is conditioning treatment before a stem cell transplant. High doses of chemotherapy and radiation damage the delicate cells lining liver blood vessels. Certain chemotherapy drugs pose higher risk, including busulfan, cyclophosphamide, and melphalan. The damage causes these vessels to swell and become blocked with blood clots and debris.
Risk factors include previous liver disease, older age at transplant, and certain genetic factors. People receiving stem cell transplants from unrelated donors face higher risk. High intensity conditioning regimens before transplant increase the chance of developing this condition. Some herbal supplements containing pyrrolizidine alkaloids can also damage liver blood vessels. Radiation therapy to the liver area may contribute to blood vessel damage.
How it's diagnosed
Doctors diagnose veno-occlusive disease by combining blood tests, physical examination, and imaging studies. Blood tests measure liver enzymes that rise when liver cells are damaged. The Gamma-Glutamyl Transferase test, or GGT, helps detect liver cell injury from blood vessel damage. Rising GGT levels along with other liver markers suggest problems with blood flow through the liver. Bilirubin levels also increase when the liver cannot process waste properly.
Rite Aid offers comprehensive blood testing that includes GGT and other liver function markers. Regular monitoring after stem cell transplant or chemotherapy helps catch problems early. Ultrasound imaging can show reduced blood flow through liver vessels and detect fluid buildup. In some cases, doctors may perform a liver biopsy to confirm the diagnosis and rule out other conditions.
Treatment options
- Defibrotide medication, which protects blood vessel lining and improves blood flow
- Careful fluid management to reduce swelling and prevent overload
- Pain management medications as needed
- Diuretics to help remove excess fluid from the body
- Low sodium diet to reduce fluid retention
- Avoiding medications that can harm the liver
- Close monitoring of blood tests to track liver function
- Supportive care in hospital for severe cases
- Liver transplant in rare, severe cases that do not respond to other treatments
Concerned about Veno-Occlusive Disease? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
They are two names for the same condition. Veno-occlusive disease was the original name doctors used. The newer term sinusoidal obstruction syndrome more accurately describes where the problem occurs in the liver. Both names refer to blocked blood vessels inside the liver.
People receiving stem cell transplants face the highest risk, especially after high dose chemotherapy. Risk increases with older age, previous liver disease, and certain genetic factors. People receiving transplants from unrelated donors or those getting high intensity conditioning regimens have higher risk. Some chemotherapy drugs outside of transplant settings can also cause this condition.
Most cases develop within 3 weeks after a stem cell transplant. The typical window is between 10 to 20 days after transplant. Some cases may appear earlier or slightly later. This is why doctors monitor liver function closely during the first month after transplant.
Prevention focuses on reducing risk during transplant preparation. Doctors may adjust chemotherapy doses or choose less toxic drug combinations. Some transplant centers use defibrotide as preventive treatment for high risk patients. Avoiding herbal supplements that damage the liver helps reduce risk. Regular monitoring allows early intervention if problems develop.
Blood tests measure liver enzymes that rise when liver cells are damaged. GGT levels increase when blood vessel damage affects liver cells. Bilirubin rises when the liver cannot process waste properly. Monitoring these markers over time helps doctors detect problems early and track treatment response.
No, the severity varies widely between patients. Mild cases may resolve on their own with supportive care and careful monitoring. Moderate cases respond well to treatment with defibrotide and fluid management. Severe cases can lead to liver failure and require intensive medical care. Early detection improves outcomes across all severity levels.
Defibrotide is a medication that protects the lining of blood vessels and helps restore normal blood flow. It reduces inflammation and prevents blood clots from forming in damaged vessels. The medication is given through an IV in the hospital. Studies show it significantly improves survival in patients with severe veno-occlusive disease.
Most cases do not recur once they resolve. The condition is tied to specific triggers like chemotherapy or transplant conditioning. Once the triggering treatment ends and the liver heals, recurrence is uncommon. However, future exposure to liver toxic treatments could potentially cause new episodes.
Recovery time depends on severity. Mild cases may improve within a few weeks with supportive care. Moderate cases treated with defibrotide often show improvement within 2 to 4 weeks. Severe cases may take several months to fully recover. Regular blood tests help doctors track healing progress.
Avoid herbal supplements containing pyrrolizidine alkaloids, which can damage liver blood vessels. Common sources include comfrey, borage, and certain teas. Follow a low sodium diet if you have fluid retention. Avoid alcohol completely as it stresses the liver. Always discuss any supplements with your transplant team before taking them.